Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The variant gambit: COVID-19’s next move
Jessica A. Plante, Brooke Mitchell, Kenneth S. Plante, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 508-515
Open Access | Times Cited: 347

Showing 1-25 of 347 citing articles:

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas, David Veyer, Artem Baidaliuk, et al.
Nature (2021) Vol. 596, Iss. 7871, pp. 276-280
Open Access | Times Cited: 2027
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Delphine Planas, Nell Saunders, Piet Maes, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 671-675
Open Access | Times Cited: 1460
The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 993
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
Akatsuki Saito, Takashi Irie, Rigel Suzuki, et al.
Nature (2021) Vol. 602, Iss. 7896, pp. 300-306
Open Access | Times Cited: 556
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Chihiro Motozono, Mako Toyoda, Jiří Zahradník, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1124-1136.e11
Open Access | Times Cited: 525
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
Katharina Röltgen, Sandra C. A. Nielsen, Oscar Silva, et al.
Cell (2022) Vol. 185, Iss. 6, pp. 1025-1040.e14
Open Access | Times Cited: 383
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Franz X. Heinz, Karin Stiasny
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 348
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
Venkata-Viswanadh Edara, Benjamin A. Pinsky, Mehul S. Suthar, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 7, pp. 664-666
Open Access | Times Cited: 345
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
Delphine Planas, David Veyer, Artem Baidaliuk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 278
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
Venkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 516-521.e3
Open Access | Times Cited: 236
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
Cell Reports (2021) Vol. 36, Iss. 3, pp. 109415-109415
Open Access | Times Cited: 233
SARS-COV-2 Variants: Differences and Potential of Immune Evasion
Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Renata Gorjão, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 208
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
Anoop Narayanan, M. Narwal, Sydney A. Majowicz, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 181
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic
Tirosh Shapira, I. Abrrey Monreal, Sébastien P. Dion, et al.
Nature (2022) Vol. 605, Iss. 7909, pp. 340-348
Open Access | Times Cited: 181
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
Yang Liu, Jianying Liu, Bryan A. Johnson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 159
A paper-based assay for the colorimetric detection of SARS-CoV-2 variants at single-nucleotide resolution
Ting Zhang, Ruijie Deng, Yuxi Wang, et al.
Nature Biomedical Engineering (2022) Vol. 6, Iss. 8, pp. 957-967
Open Access | Times Cited: 156
Defining the risk of SARS-CoV-2 variants on immune protection
Marciela M. DeGrace, Elodie Ghedin, Matthew B. Frieman, et al.
Nature (2022) Vol. 605, Iss. 7911, pp. 640-652
Open Access | Times Cited: 154
Viral variant-resolved wastewater surveillance of SARS-CoV-2 at national scale
Fabian Amman, Rudolf Markt, Lukas Endler, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 12, pp. 1814-1822
Open Access | Times Cited: 152
SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1
Xiao Sun, Yingzhi Liu, Ziheng Huang, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1240-1254
Open Access | Times Cited: 149
Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct
Anna Z. Mykytyn, Melanie Rissmann, Adinda Kok, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 145
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19
Lok-Yin Roy Wong, Jian Zheng, Kevin Wilhelmsen, et al.
Nature (2022) Vol. 605, Iss. 7908, pp. 146-151
Open Access | Times Cited: 140
Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study
Suzanne Pickering, Rahul Batra, Blair Merrick, et al.
The Lancet Microbe (2021) Vol. 2, Iss. 9, pp. e461-e471
Open Access | Times Cited: 137
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity
Rachid Essalmani, Jaspreet Jain, Delia Susan‐Resiga, et al.
Journal of Virology (2022) Vol. 96, Iss. 8
Open Access | Times Cited: 135
Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
Bryan A. Johnson, Yiyang Zhou, Kumari G. Lokugamage, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010627-e1010627
Open Access | Times Cited: 131
Page 1 - Next Page

Scroll to top